Research information only, not medical advice. In trials, tirzepatide produced large weight loss: a 2026 network meta-analysis found the 15 mg dose gave the greatest reduction, about 18% of body weight, and the SURMOUNT-1 obesity trial reported roughly 15-21% at 72 weeks across doses. Results outside trials vary.
The weight changes with tirzepatide come from large randomised trials, not personal transformations. In the SURMOUNT-1 obesity trial, once-weekly tirzepatide produced mean weight reductions of about 15% to 21% across the 5/10/15 mg doses at 72 weeks, versus roughly 3% with placebo (Jastreboff et al., NEJM 2022). A 2026 network meta-analysis found the 15 mg dose gave the greatest percent weight reduction of the medications compared (about 18%). This is trial data for an approved drug, reported as evidence rather than medical advice.
For the full evidence base, clinical trials, and regulatory status, see the Tirzepatide research overview . Related: tirzepatide side effects , tirzepatide dosage .
Sources
Frequently asked questions
- How much weight can you lose on tirzepatide?
- In the SURMOUNT-1 trial, mean weight reduction was about 15-21% at 72 weeks across the 5, 10 and 15 mg doses; a 2026 meta-analysis put the 15 mg reduction near 18%. Individual results outside trials vary.
- How long does tirzepatide take to work?
- Trial weight-loss figures are measured over long periods — SURMOUNT-1 reported its results at 72 weeks, with the dose increased gradually over the first weeks.
Updated · sourced to primary documents